Brachytherapy Market Size, Share & Trends Analysis Report By Product (Seeds, Applicators & Afterloaders, Electronic Brachytherapy), By Dosage Type, By Application (Prostate, Gynecological & Breast Cancer)- Global Industry Analysis, Share, Growth, Regional Outlook And Forecasts, 2021-2027

The global Brachytherapy market gathered revenue around USD 789.2 Million in 2020 and market is set to grow USD 106.2 Million by the end of 2027 and is estimated to expand at a modest CAGR of 9.20% during the prediction period 2021 to 2027. The increasing prevalence of cancer, technological advancements, and a significant rise in the adoption of brachytherapy are expected to drive the growth of the market during the forecast period. Brachytherapy is a type of radiation therapy used for the treatment of cancer. The radioactive materials are placed inside the body with the help of catheters.

Moreover, government hospitals in developing countries are installing advanced systems to provide better quality treatment for their patients. For instance, in August 2019, Eckert and Ziegler BEBIG delivered and installed SagiNova HDR afterloader at BP Koirala Memorial Cancer Hospital of Nepal. SagiNova is suitable for interstitial breast implants. Hence, the use of such brachytherapy systems by hospitals is expected to fuel market growth.

The new study made on Brachytherapy market includes crucial information on market share, market size, and growth rate for the forecast period 2021 to 2027. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics.

COVID-19 Impact:

The industrial report mentions about the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The Brachytherapy report proficiently explains about the resulting factors and concerns of manufacturers. Researchers have also well-explained about how the producers and providers will tackle with the ongoing epidemic and the key strategies to be adopted post pandemic for turning their businesses back to normal.

Regional Insights:

The Brachytherapy market is segmented as North America, South America, Europe, Asia Pacific, and Middle East and Africa. Researchers have thoroughly studied about the historical market. With extensive research, experts have offered details on the current and the forecast demand made by these regions. The Brachytherapy report also includes highlights on the prevailing product demanded by end users and end customers for better understanding of product demand by producers. This will help the producers and the marketing executives to plan their production quantity and plan effective marketing strategies to more buyers. Businesses can hence, increase their product portfolio and expand their global presence. Brachytherapy market research report further offers information on the unexplored areas in these regions to help the producers to plan promotional strategies and create demand for their new and updated products. This will again help the manufacturers to increase their customers and emerge as leaders in the near future.

Report Highlights Details
Market Size US$ 106.2 Million by 2027
Growth Rate CAGR of 9.20% From 2021 to 2027
Base Year 2020
Historic Data 2017 to 2020
No. of Pages 250
Forecast Period 2021 to 2027
Segments Covered Product,Dosage Type,Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Varian Medical Systems, Inc.,Becton,Dickinson & Company,Elekta AB,Isoray Medical, Inc.,Eckert & Ziegler BEBIG,iCAD, Inc.,CIVCO Medical Solutions,Theragenics Corporation

Major Players Covered in this Report

The updated market research report on Brachytherapy market allows the buyers and manufacturers to stay updated with the current market trends, ongoing happenings, and a clear picture on the market scenario. List of key players included in the research report will help the market vendors to know their market position and plan more operational strategies to gain topmost position among other players. The report offers crucial company information on each market player, such as company profile, financial information, and recently adopted growth strategies. This will help other existing players and the new entrants to plan strategies and establish their presence in the market.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Significant Market Participants Operational in the Brachytherapy Market are:

the brachytherapy market include:

  • Varian Medical Systems, Inc.
  • Becton
  • Dickinson & Company
  • Elekta AB
  • Isoray Medical, Inc.
  • Eckert & Ziegler BEBIG
  • iCAD, Inc.
  • CIVCO Medical Solutions
  • Theragenics Corporation

Market Segmentation:

The report is divided into major categories comprising product, application, regions and others. Every segment is further sub-segmented into several sub-segmented that are deeply analyzed by experts to offer valuable information to the buyers and market players. Every segment is studied thoroughly in order to offer a better picture to the buyers and stakeholders to benefit from. Information like highest prevailing product, highly demanded product by the application segment and end users are rightly mentioned in the Brachytherapy report.

  • Product Outlook
    • Seeds
    • Applicators & Afterloaders
    • Electronic Brachytherapy
  • Dosage Type Outlook
    • HDR Brachytherapy
    • LDR Brachytherapy
  • Application Outlook
    • Prostate Cancer
    • Gynecological Cancer
    • Breast Cancer
    • Others

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Manufacturers

The report includes comprehensive company profiling of leading and emerging companies competing in the global Brachytherapy market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Brachytherapy market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.

In this study, the years considered to estimate the market size of Brachytherapy are as follows:

  • History Year: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Year 2021 to 2027

The Queries answered by Brachytherapy Market Research Report include:

  • What are the key producers, equipment suppliers, raw material suppliers, end users, distributors and traders in the Brachytherapy Market?
  • What are the crucial factors impacting the Brachytherapy Market Growth?
  • What are production processes, major problems or obstacles, and solutions to tone down the development risk?
  • What is the contribution made by regional manufacturers to the overall market?
  • What are the major market segment, influential trends, market potential, and key challenges that the market is witnessing?

Research Methodology

In order to compile the research report, we conducted in-depth interviews and discussions with a number of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research. We reviewed key players’ product literature, annual reports, press releases, and relevant documents for competitive analysis and market understanding. Secondary research also includes a search of recent trade, technical writing, internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise market data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, and SEC filings, internal and external proprietary databases, and relevant patent and regulatory databases, national government documents, statistical databases, and market reports, news articles, press releases, and webcasts specific to companies operating in the market, National government documents, statistical databases, and market reports.

Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews for each market, category, segment, and sub-segment across geographies. We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competitive landscape, and outlook, etc. These help validate and strengthen secondary research findings. These also help develop the analysis team’s expertise and market understanding.

OBJECTIVES OF THE STUDY

  • To analyze and forecast the Brachytherapy market, in terms of value and volume
  • To provide information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To define, segment, and project the size of the global Brachytherapy market on the product type, and end-use industry
  • To project the size of the market, with respect to five main regions, namely, North America, Europe, Asia Pacific (APAC), the Middle East & Africa, and South America, with their key countries
  • To strategically analyze micromarkets with respect to individual growth trends, growth prospects, and their contribution to the total market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
  • To strategically profile key players and comprehensively analyze their core competencies
  • To track and analyze research & development (R&D) and competitive developments such as joint ventures, mergers & acquisitions, and new product developments in the Brachytherapy market

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Brachytherapy Market, By Product

7.1.  Brachytherapy Market, by Product, 2021-2027

7.1.1.     Seeds

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Applicators & Afterloaders

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Applicators & Afterloaders

7.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Brachytherapy Market, By Dosage Type

8.1.  Brachytherapy Market, by Dosage Type, 2021-2027

8.1.1.     HDR Brachytherapy

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     HDR Brachytherapy

8.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Brachytherapy Market, By Application

9.1.  Brachytherapy Market, by Application, 2021-2027

9.1.1.     Prostate Cancer

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Prostate Cancer

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Breast Cancer

9.1.3.1.          Market Revenue and Forecast (2016-2027)

9.1.4.     Others

9.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Brachytherapy  Market, Regional Estimates and Trend Forecast

10.1.          North America

10.1.1.  Market Revenue and Forecast, by Product (2016-2027)

10.1.2.  Market Revenue and Forecast, by Dosage Type (2016-2027)

10.1.3.  Market Revenue and Forecast, by Application (2016-2027)

10.1.4.  U.S.

10.1.4.1.       Market Revenue and Forecast, by Product (2016-2027)

10.1.4.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.1.4.3.       Market Revenue and Forecast, by Application (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.       Market Revenue and Forecast, by Product (2016-2027)

10.1.5.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.1.5.3.       Market Revenue and Forecast, by Application (2016-2027)

10.2.          Europe

10.2.1.  Market Revenue and Forecast, by Product (2016-2027)

10.2.2.  Market Revenue and Forecast, by Dosage Type (2016-2027)

10.2.3.  Market Revenue and Forecast, by Application (2016-2027)

10.2.4.  UK

10.2.4.1.       Market Revenue and Forecast, by Product (2016-2027)

10.2.4.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.2.4.3.       Market Revenue and Forecast, by Application (2016-2027)

10.2.5.  Germany

10.2.5.1.       Market Revenue and Forecast, by Product (2016-2027)

10.2.5.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.2.5.3.       Market Revenue and Forecast, by Application (2016-2027)

10.2.6.  France

10.2.6.1.       Market Revenue and Forecast, by Product (2016-2027)

10.2.6.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.2.6.3.       Market Revenue and Forecast, by Application (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.       Market Revenue and Forecast, by Product (2016-2027)

10.2.7.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.2.7.3.       Market Revenue and Forecast, by Application (2016-2027)

10.3.          APAC

10.3.1.  Market Revenue and Forecast, by Product (2016-2027)

10.3.2.  Market Revenue and Forecast, by Dosage Type (2016-2027)

10.3.3.  Market Revenue and Forecast, by Application (2016-2027)

10.3.4.  India

10.3.4.1.       Market Revenue and Forecast, by Product (2016-2027)

10.3.4.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.3.4.3.       Market Revenue and Forecast, by Application (2016-2027)

10.3.5.  China

10.3.5.1.       Market Revenue and Forecast, by Product (2016-2027)

10.3.5.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.3.5.3.       Market Revenue and Forecast, by Application (2016-2027)

10.3.6.  Japan

10.3.6.1.       Market Revenue and Forecast, by Product (2016-2027)

10.3.6.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.3.6.3.       Market Revenue and Forecast, by Application (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.       Market Revenue and Forecast, by Product (2016-2027)

10.3.7.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.3.7.3.       Market Revenue and Forecast, by Application (2016-2027)

10.4.          MEA

10.4.1.  Market Revenue and Forecast, by Product (2016-2027)

10.4.2.  Market Revenue and Forecast, by Dosage Type (2016-2027)

10.4.3.  Market Revenue and Forecast, by Application (2016-2027)

10.4.4.  GCC

10.4.4.1.       Market Revenue and Forecast, by Product (2016-2027)

10.4.4.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.4.4.3.       Market Revenue and Forecast, by Application (2016-2027)

10.4.5.  North Africa

10.4.5.1.       Market Revenue and Forecast, by Product (2016-2027)

10.4.5.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.4.5.3.       Market Revenue and Forecast, by Application (2016-2027)

10.4.6.  South Africa

10.4.6.1.       Market Revenue and Forecast, by Product (2016-2027)

10.4.6.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.4.6.3.       Market Revenue and Forecast, by Application (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.       Market Revenue and Forecast, by Product (2016-2027)

10.4.7.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.4.7.3.       Market Revenue and Forecast, by Application (2016-2027)

10.5.          Latin America

10.5.1.  Market Revenue and Forecast, by Product (2016-2027)

10.5.2.  Market Revenue and Forecast, by Dosage Type (2016-2027)

10.5.3.  Market Revenue and Forecast, by Application (2016-2027)

10.5.4.  Brazil

10.5.4.1.       Market Revenue and Forecast, by Product (2016-2027)

10.5.4.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.5.4.3.       Market Revenue and Forecast, by Application (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.       Market Revenue and Forecast, by Product (2016-2027)

10.5.5.2.       Market Revenue and Forecast, by Dosage Type (2016-2027)

10.5.5.3.       Market Revenue and Forecast, by Application (2016-2027)

Chapter 11.   Company Profiles

11.1.                 Varian Medical Systems, Inc

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.                 Becton,Dickinson & Company

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.                 Elekta AB

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.                 Isoray Medical, Inc.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.                 Eckert & Ziegler BEBIG,iCAD, Inc

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.                 CIVCO Medical Solutions

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.                 Theragenics Corporation

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

Chapter 12.   Research Methodology

12.1.                 Primary Research

12.2.                 Secondary Research

12.3.                 Assumptions

Chapter 13.   Appendix

13.1.                 About Us

13.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers